Since serum levels of Flt-3L were already increased in pSS patients at the time of lymphoma diagnosis, it can be speculated that high levels of Flt-3L may also be detectable in association with non-malignant lymphoproliferative disorder many years before the diagnosis of NHL. The gene discussed is FLT3LG; the disease is lymphoma.